European Patent Office Invalidates Patent For Nitric Oxide

Law360, New York (November 17, 2004, 12:00 AM EST) -- The European Patent Office has dealt a huge blow to German industrial conglomerate Linde AG by invalidating a patent that gave it exclusive European rights to the use of nitric oxide in the treatment of respiratory failure.

The decision is a victory for rivals Air Products of the U.S. and Air Liquide of France, which have been challenging the patent for six years. Air Products first objected to the issuance of the European patent in 1998, but the EPO rejected this action in a decision dated...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.